Share Price and Basic Stock Data
Last Updated: November 8, 2025, 4:15 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Tijaria Polypipes Ltd operates in the plastics sector, specifically focusing on pipes and fittings. The company’s recent revenue trends reflect significant challenges, with sales declining sharply from ₹149.53 Cr in FY 2019 to a mere ₹13.85 Cr in FY 2023. The revenue for FY 2024 further plummeted to ₹0.15 Cr, indicating a substantial contraction in business activity. Quarterly sales also display a concerning trajectory, with the latest figures reporting ₹0.04 Cr in June 2023 and dropping to ₹0.00 Cr in subsequent quarters. This drastic reduction in sales raises questions about the company’s operational viability and market positioning. In an industry that typically demands consistent growth, Tijaria’s performance starkly contrasts with sector norms where companies often report stable or growing revenues. The stark drop in sales underscores the urgent need for strategic changes or operational restructuring to regain market share and restore revenue levels.
Profitability and Efficiency Metrics
The profitability metrics for Tijaria Polypipes Ltd exhibit a troubling trend, with the company reporting negative operating profits consistently. The operating profit margin (OPM) stood at -30.69% for FY 2023 and deteriorated further to -200.00% for FY 2024. This indicates that the company has not only been unable to generate profits but is also incurring increasing losses relative to its revenues. The net profit figures further illustrate this dire situation, with a net loss of ₹9.46 Cr in FY 2023 and an even larger loss expected in FY 2024 at ₹2.92 Cr. Additionally, the interest coverage ratio (ICR) of 1.12x suggests that the company barely covers its interest obligations, posing significant risks to its financial stability. Efficiency metrics also reveal a concerning cash conversion cycle, which stood at 503.84 days in FY 2023, indicating prolonged periods before cash is recovered from sales. These factors collectively highlight significant operational inefficiencies and a pressing need for turnaround strategies.
Balance Sheet Strength and Financial Ratios
Analyzing the balance sheet of Tijaria Polypipes Ltd reveals a precarious financial position, characterized by high borrowings and negative reserves. The company reported borrowings of ₹77.40 Cr alongside reserves of -₹61.13 Cr, which raises serious concerns regarding its solvency and financial health. The long-term debt to equity ratio stood at -2.02, indicating that the company has more liabilities than equity, which is atypical for a healthy business. Moreover, the book value per share is reported at -₹11.35, signifying that shareholders may face potential losses in equity value. The current ratio of 1.66 suggests that while the company can cover its short-term liabilities, it does so with little room for error, pointing to liquidity constraints. Overall, the balance sheet reflects a company struggling with financial distress, which could deter potential investors and lenders from supporting its operations.
Shareholding Pattern and Investor Confidence
The shareholding structure of Tijaria Polypipes Ltd indicates a dominant public ownership at 60.13%, while promoters hold 35.27%. The presence of foreign institutional investors (FIIs) at 4.61% marks a slight recovery from previous lows, suggesting some renewed interest in the company’s potential. However, the absence of domestic institutional investors (DIIs) raises concerns about institutional confidence in the company’s future. The number of shareholders has steadily increased to 11,546, indicating a degree of retail interest despite the company’s financial struggles. This could suggest that investors are either speculating on a turnaround or are drawn to the low share price of ₹6.51, which may appear attractive. However, the overall lack of institutional backing and the high public shareholding could lead to volatility in the stock price, depending on market sentiment and operational developments.
Outlook, Risks, and Final Insight
The outlook for Tijaria Polypipes Ltd remains uncertain, primarily due to its ongoing financial distress and declining revenues. Risks include the potential for further deterioration in profitability, as evidenced by negative profit margins and high operational costs. Additionally, the company’s heavy reliance on debt could lead to liquidity crises if revenues do not recover. However, if Tijaria can successfully implement strategic changes to improve operational efficiencies and restore sales, there may be potential for recovery. Furthermore, given the low market capitalization of ₹18.6 Cr and a share price of ₹6.51, any positive developments could significantly enhance investor sentiment. Conversely, continued losses and a failure to stabilize operations could lead to a more severe decline in shareholder value. The company must navigate these challenges effectively to regain investor confidence and achieve sustainable growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Tijaria Polypipes Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dutron Polymers Ltd | 73.2 Cr. | 122 | 198/110 | 34.9 | 49.1 | 1.23 % | 12.3 % | 9.68 % | 10.0 |
| Captain Polyplast Ltd | 492 Cr. | 82.2 | 128/58.4 | 24.9 | 28.0 | 0.00 % | 16.1 % | 15.0 % | 2.00 |
| Captain Pipes Ltd | 196 Cr. | 12.8 | 21.0/11.7 | 55.1 | 2.69 | 0.00 % | 17.0 % | 13.5 % | 1.00 |
| Caprihans India Ltd | 171 Cr. | 117 | 184/108 | 196 | 0.00 % | 0.78 % | 18.9 % | 10.0 | |
| Ashish Polyplast Ltd | 12.4 Cr. | 36.6 | 63.9/30.0 | 41.5 | 19.8 | 0.00 % | 5.09 % | 2.58 % | 10.0 |
| Industry Average | 6,049.00 Cr | 222.36 | 51.23 | 80.49 | 0.21% | 10.40% | 10.62% | 8.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.91 | 0.09 | 0.00 | 3.84 | 0.04 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 11.53 | 0.43 | 0.29 | 5.86 | 0.23 | 0.01 | 0.03 | 0.20 | 0.17 | 0.04 | 0.04 | 0.05 | 0.10 |
| Operating Profit | -1.62 | -0.34 | -0.29 | -2.02 | -0.19 | -0.01 | -0.03 | -0.09 | -0.17 | -0.04 | -0.04 | -0.05 | -0.10 |
| OPM % | -16.35% | -377.78% | -52.60% | -475.00% | -81.82% | ||||||||
| Other Income | 0.06 | 0.03 | 0.03 | 0.04 | 0.02 | 0.04 | 0.03 | 0.08 | 0.13 | 0.05 | 0.06 | -3.06 | 0.02 |
| Interest | 1.96 | 0.03 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.85 | 0.83 | 0.83 | 0.80 | 0.68 | 0.69 | 0.69 | 0.70 | 0.58 | 0.94 | 0.76 | 0.03 | 0.19 |
| Profit before tax | -4.37 | -1.17 | -1.10 | -2.79 | -0.85 | -0.66 | -0.69 | -0.71 | -0.62 | -0.93 | -0.74 | -3.14 | -0.27 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -4.37 | -1.17 | -1.11 | -2.80 | -0.85 | -0.66 | -0.69 | -0.71 | -0.62 | -0.93 | -0.74 | -3.14 | -0.27 |
| EPS in Rs | -1.53 | -0.41 | -0.39 | -0.98 | -0.30 | -0.23 | -0.24 | -0.25 | -0.22 | -0.32 | -0.26 | -1.10 | -0.09 |
Last Updated: August 20, 2025, 2:15 am
Below is a detailed analysis of the quarterly data for Tijaria Polypipes Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Expenses, as of Jun 2025, the value is 0.10 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.05 Cr. (Mar 2025) to 0.10 Cr., marking an increase of 0.05 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.10 Cr.. The value appears to be declining and may need further review. It has decreased from -0.05 Cr. (Mar 2025) to -0.10 Cr., marking a decrease of 0.05 Cr..
- For OPM %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Other Income, as of Jun 2025, the value is 0.02 Cr.. The value appears strong and on an upward trend. It has increased from -3.06 Cr. (Mar 2025) to 0.02 Cr., marking an increase of 3.08 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.19 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.03 Cr. (Mar 2025) to 0.19 Cr., marking an increase of 0.16 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.27 Cr.. The value appears strong and on an upward trend. It has increased from -3.14 Cr. (Mar 2025) to -0.27 Cr., marking an increase of 2.87 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is -0.27 Cr.. The value appears strong and on an upward trend. It has increased from -3.14 Cr. (Mar 2025) to -0.27 Cr., marking an increase of 2.87 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.09. The value appears strong and on an upward trend. It has increased from -1.10 (Mar 2025) to -0.09, marking an increase of 1.01.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:16 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 108.57 | 69.11 | 87.03 | 63.54 | 76.34 | 149.53 | 73.39 | 62.46 | 54.88 | 13.85 | 0.15 | -0.00 | 0.00 |
| Expenses | 99.49 | 61.05 | 80.92 | 66.07 | 83.95 | 129.73 | 64.62 | 66.11 | 63.93 | 18.10 | 0.45 | 0.27 | 0.23 |
| Operating Profit | 9.08 | 8.06 | 6.11 | -2.53 | -7.61 | 19.80 | 8.77 | -3.65 | -9.05 | -4.25 | -0.30 | -0.27 | -0.23 |
| OPM % | 8.36% | 11.66% | 7.02% | -3.98% | -9.97% | 13.24% | 11.95% | -5.84% | -16.49% | -30.69% | -200.00% | ||
| Other Income | -0.00 | 5.05 | 0.19 | -1.42 | -1.06 | 0.67 | 0.36 | 0.91 | -0.11 | 0.13 | 0.17 | -2.83 | -2.93 |
| Interest | 8.85 | 8.73 | 9.10 | 7.18 | 7.51 | 7.94 | 6.40 | 6.51 | 8.42 | 2.01 | 0.02 | 0.02 | 0.00 |
| Depreciation | 10.43 | 13.53 | 11.80 | 9.78 | 8.23 | 6.34 | 5.20 | 4.76 | 4.13 | 3.32 | 2.76 | 2.31 | 1.92 |
| Profit before tax | -10.20 | -9.15 | -14.60 | -20.91 | -24.41 | 6.19 | -2.47 | -14.01 | -21.71 | -9.45 | -2.91 | -5.43 | -5.08 |
| Tax % | 5.98% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | |
| Net Profit | -10.80 | -9.15 | -14.60 | -20.92 | -24.41 | 6.19 | -2.46 | -14.01 | -21.70 | -9.46 | -2.92 | -5.43 | -5.08 |
| EPS in Rs | -4.57 | -3.87 | -6.18 | -8.85 | -10.33 | 2.32 | -0.86 | -4.89 | -7.58 | -3.30 | -1.02 | -1.90 | -1.77 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 15.28% | -59.56% | -43.29% | -16.68% | 125.36% | -139.74% | -469.51% | -54.89% | 56.41% | 69.13% | -85.96% |
| Change in YoY Net Profit Growth (%) | 0.00% | -74.84% | 16.28% | 26.61% | 142.04% | -265.10% | -329.77% | 414.62% | 111.29% | 12.73% | -155.09% |
Tijaria Polypipes Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 1% |
| 3 Years: | 24% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 3% |
| 3 Years: | 14% |
| 1 Year: | -52% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 1:46 pm
Balance Sheet
Last Updated: June 16, 2025, 11:12 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 23.63 | 23.63 | 23.63 | 23.63 | 23.63 | 26.72 | 28.63 | 28.63 | 28.63 | 28.63 | 28.63 | 28.63 |
| Reserves | 55.50 | 46.31 | 31.71 | 10.79 | -11.84 | -5.37 | -7.73 | -21.66 | -43.35 | -52.78 | -55.70 | -61.13 |
| Borrowings | 65.58 | 62.07 | 64.63 | 67.23 | 69.90 | 54.12 | 50.76 | 65.88 | 69.15 | 76.36 | 72.41 | 77.40 |
| Other Liabilities | 10.00 | 13.54 | 10.87 | 13.36 | 30.23 | 35.10 | 24.14 | 24.02 | 13.27 | 9.32 | 9.18 | 9.58 |
| Total Liabilities | 154.71 | 145.55 | 130.84 | 115.01 | 111.92 | 110.57 | 95.80 | 96.87 | 67.70 | 61.53 | 54.52 | 54.48 |
| Fixed Assets | 90.33 | 75.67 | 65.41 | 57.71 | 47.13 | 39.19 | 34.52 | 33.56 | 28.79 | 25.31 | 22.55 | 17.12 |
| CWIP | 7.03 | 1.25 | 1.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 57.35 | 68.63 | 64.07 | 57.30 | 64.79 | 71.38 | 61.28 | 63.18 | 38.91 | 36.22 | 31.97 | 37.36 |
| Total Assets | 154.71 | 145.55 | 130.84 | 115.01 | 111.92 | 110.57 | 95.80 | 96.87 | 67.70 | 61.53 | 54.52 | 54.48 |
Below is a detailed analysis of the balance sheet data for Tijaria Polypipes Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 28.63 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 28.63 Cr..
- For Reserves, as of Mar 2025, the value is -61.13 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -55.70 Cr. (Mar 2024) to -61.13 Cr., marking a decline of 5.43 Cr..
- For Borrowings, as of Mar 2025, the value is 77.40 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 72.41 Cr. (Mar 2024) to 77.40 Cr., marking an increase of 4.99 Cr..
- For Other Liabilities, as of Mar 2025, the value is 9.58 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.18 Cr. (Mar 2024) to 9.58 Cr., marking an increase of 0.40 Cr..
- For Total Liabilities, as of Mar 2025, the value is 54.48 Cr.. The value appears to be improving (decreasing). It has decreased from 54.52 Cr. (Mar 2024) to 54.48 Cr., marking a decrease of 0.04 Cr..
- For Fixed Assets, as of Mar 2025, the value is 17.12 Cr.. The value appears to be declining and may need further review. It has decreased from 22.55 Cr. (Mar 2024) to 17.12 Cr., marking a decrease of 5.43 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 37.36 Cr.. The value appears strong and on an upward trend. It has increased from 31.97 Cr. (Mar 2024) to 37.36 Cr., marking an increase of 5.39 Cr..
- For Total Assets, as of Mar 2025, the value is 54.48 Cr.. The value appears to be declining and may need further review. It has decreased from 54.52 Cr. (Mar 2024) to 54.48 Cr., marking a decrease of 0.04 Cr..
However, the Borrowings (77.40 Cr.) are higher than the Reserves (-61.13 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -56.50 | -54.01 | -58.52 | -69.76 | -77.51 | -34.32 | -41.99 | -69.53 | -78.20 | -80.61 | -72.71 | -77.67 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 93.70 | 167.26 | 103.97 | 152.86 | 163.47 | 136.04 | 198.19 | 218.50 | 167.67 | 659.90 | 60,784.67 | |
| Inventory Days | 71.18 | 190.53 | 168.43 | 147.34 | 85.65 | 29.43 | 100.16 | 109.28 | 39.39 | 11.91 | 997.67 | |
| Days Payable | 31.01 | 85.09 | 46.37 | 71.98 | 161.85 | 116.40 | 175.15 | 114.50 | 72.58 | 167.97 | 16,863.00 | |
| Cash Conversion Cycle | 133.86 | 272.71 | 226.03 | 228.22 | 87.27 | 49.07 | 123.19 | 213.27 | 134.49 | 503.84 | 44,919.33 | |
| Working Capital Days | 13.72 | 67.66 | 15.81 | 57.79 | -31.08 | 34.20 | 80.12 | 153.69 | 67.91 | 324.15 | 30,343.67 | |
| ROCE % | -0.90% | -3.35% | -4.29% | -10.73% | -16.85% | 18.22% | 5.36% | -10.44% | -20.41% | -13.88% | -5.88% | -5.05% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -2.30 | -1.23 | -3.30 | -7.57 | -4.87 |
| Diluted EPS (Rs.) | -2.30 | -1.23 | -3.30 | -7.57 | -4.87 |
| Cash EPS (Rs.) | -1.09 | -0.05 | -2.60 | -6.14 | -3.23 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -11.35 | -9.46 | -8.44 | -5.14 | 2.43 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -11.35 | -9.46 | -8.44 | -5.14 | 2.43 |
| Revenue From Operations / Share (Rs.) | 0.00 | 0.05 | 4.84 | 19.17 | 21.82 |
| PBDIT / Share (Rs.) | 0.01 | -0.04 | -1.44 | -3.20 | -1.56 |
| PBIT / Share (Rs.) | -0.79 | -1.01 | -2.14 | -4.64 | -3.23 |
| PBT / Share (Rs.) | -0.80 | -1.02 | -3.30 | -7.58 | -4.89 |
| Net Profit / Share (Rs.) | -1.90 | -1.02 | -3.30 | -7.58 | -4.89 |
| PBDIT Margin (%) | 0.00 | -79.03 | -29.67 | -16.67 | -7.16 |
| PBIT Margin (%) | 0.00 | -1940.33 | -44.21 | -24.20 | -14.79 |
| PBT Margin (%) | 0.00 | -1963.75 | -68.28 | -39.54 | -22.43 |
| Net Profit Margin (%) | 0.00 | -1963.75 | -68.28 | -39.54 | -22.43 |
| Return on Networth / Equity (%) | 0.00 | 0.00 | 0.00 | 0.00 | -201.27 |
| Return on Capital Employeed (%) | -6.91 | -7.50 | -14.82 | -30.52 | -13.83 |
| Return On Assets (%) | -9.96 | -5.34 | -15.36 | -32.05 | -14.46 |
| Long Term Debt / Equity (X) | -2.02 | -2.42 | -2.71 | -3.96 | 8.60 |
| Total Debt / Equity (X) | -2.38 | -2.67 | -3.16 | -4.70 | 9.46 |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.21 | 0.66 | 0.64 |
| Current Ratio (X) | 1.66 | 1.88 | 1.71 | 1.54 | 2.04 |
| Quick Ratio (X) | 1.64 | 1.86 | 1.69 | 1.30 | 1.55 |
| Inventory Turnover Ratio (X) | 0.00 | 0.10 | 3.43 | 4.94 | 3.54 |
| Interest Coverage Ratio (X) | 1.12 | -6.99 | -1.24 | -1.09 | -0.93 |
| Interest Coverage Ratio (Post Tax) (X) | -128.14 | -171.73 | -1.84 | -1.58 | -1.94 |
| Enterprise Value (Cr.) | 91.12 | 107.14 | 84.52 | 84.89 | 78.81 |
| EV / Net Operating Revenue (X) | 0.00 | 721.44 | 6.10 | 1.55 | 1.26 |
| EV / EBITDA (X) | 4578.83 | -912.86 | -20.57 | -9.27 | -17.60 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 245.76 | 0.90 | 0.33 | 0.28 |
| Price / BV (X) | -0.47 | -1.35 | -0.52 | -1.25 | 2.59 |
| Price / Net Operating Revenue (X) | 0.00 | 250.00 | 0.90 | 0.33 | 0.28 |
| EarningsYield | -0.34 | -0.07 | -0.75 | -1.18 | -0.77 |
After reviewing the key financial ratios for Tijaria Polypipes Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -2.30. This value is below the healthy minimum of 5. It has decreased from -1.23 (Mar 24) to -2.30, marking a decrease of 1.07.
- For Diluted EPS (Rs.), as of Mar 25, the value is -2.30. This value is below the healthy minimum of 5. It has decreased from -1.23 (Mar 24) to -2.30, marking a decrease of 1.07.
- For Cash EPS (Rs.), as of Mar 25, the value is -1.09. This value is below the healthy minimum of 3. It has decreased from -0.05 (Mar 24) to -1.09, marking a decrease of 1.04.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -11.35. It has decreased from -9.46 (Mar 24) to -11.35, marking a decrease of 1.89.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -11.35. It has decreased from -9.46 (Mar 24) to -11.35, marking a decrease of 1.89.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.00. It has decreased from 0.05 (Mar 24) to 0.00, marking a decrease of 0.05.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 2. It has increased from -0.04 (Mar 24) to 0.01, marking an increase of 0.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.79. This value is below the healthy minimum of 0. It has increased from -1.01 (Mar 24) to -0.79, marking an increase of 0.22.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.80. This value is below the healthy minimum of 0. It has increased from -1.02 (Mar 24) to -0.80, marking an increase of 0.22.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -1.90. This value is below the healthy minimum of 2. It has decreased from -1.02 (Mar 24) to -1.90, marking a decrease of 0.88.
- For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -79.03 (Mar 24) to 0.00, marking an increase of 79.03.
- For PBIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -1,940.33 (Mar 24) to 0.00, marking an increase of 1,940.33.
- For PBT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -1,963.75 (Mar 24) to 0.00, marking an increase of 1,963.75.
- For Net Profit Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -1,963.75 (Mar 24) to 0.00, marking an increase of 1,963.75.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is -6.91. This value is below the healthy minimum of 10. It has increased from -7.50 (Mar 24) to -6.91, marking an increase of 0.59.
- For Return On Assets (%), as of Mar 25, the value is -9.96. This value is below the healthy minimum of 5. It has decreased from -5.34 (Mar 24) to -9.96, marking a decrease of 4.62.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -2.02. This value is below the healthy minimum of 0.2. It has increased from -2.42 (Mar 24) to -2.02, marking an increase of 0.40.
- For Total Debt / Equity (X), as of Mar 25, the value is -2.38. This value is within the healthy range. It has increased from -2.67 (Mar 24) to -2.38, marking an increase of 0.29.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Current Ratio (X), as of Mar 25, the value is 1.66. This value is within the healthy range. It has decreased from 1.88 (Mar 24) to 1.66, marking a decrease of 0.22.
- For Quick Ratio (X), as of Mar 25, the value is 1.64. This value is within the healthy range. It has decreased from 1.86 (Mar 24) to 1.64, marking a decrease of 0.22.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 0.10 (Mar 24) to 0.00, marking a decrease of 0.10.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.12. This value is below the healthy minimum of 3. It has increased from -6.99 (Mar 24) to 1.12, marking an increase of 8.11.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -128.14. This value is below the healthy minimum of 3. It has increased from -171.73 (Mar 24) to -128.14, marking an increase of 43.59.
- For Enterprise Value (Cr.), as of Mar 25, the value is 91.12. It has decreased from 107.14 (Mar 24) to 91.12, marking a decrease of 16.02.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 721.44 (Mar 24) to 0.00, marking a decrease of 721.44.
- For EV / EBITDA (X), as of Mar 25, the value is 4,578.83. This value exceeds the healthy maximum of 15. It has increased from -912.86 (Mar 24) to 4,578.83, marking an increase of 5,491.69.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 245.76 (Mar 24) to 0.00, marking a decrease of 245.76.
- For Price / BV (X), as of Mar 25, the value is -0.47. This value is below the healthy minimum of 1. It has increased from -1.35 (Mar 24) to -0.47, marking an increase of 0.88.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 250.00 (Mar 24) to 0.00, marking a decrease of 250.00.
- For EarningsYield, as of Mar 25, the value is -0.34. This value is below the healthy minimum of 5. It has decreased from -0.07 (Mar 24) to -0.34, marking a decrease of 0.27.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Tijaria Polypipes Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -6.91% (Industry Average ROCE: 10.4%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 10.62%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -128.14
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.64
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 51.23)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -2.38
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plastics - Pipes & Fittings | SP-1-2316, RIICO Industries Area, Jaipur Rajasthan 302022 | investors@tijaria-pipes.com http://www.tijaria-pipes.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Alok Jain Tijaria | Managing Director |
| Mr. Vikas Jain Tijaria | Whole Time Director - Marketing |
| Mr. Praveen Jain Tijaria | Whole Time Director - Production |
| Mr. Vineet Jain Tijaria | Whole Time Director - Finance |
| Ms. Khushi Nagrath | Ind. Non-Executive Woman Director |
| Mr. Ashok Kumar | Ind. Non-Executive Director |
| Mrs. Anjali Udhwani | Ind. Non-Executive Woman Director |
| Mrs. Sonu Surana | Ind. Non-Executive Woman Director |
FAQ
What is the intrinsic value of Tijaria Polypipes Ltd?
Tijaria Polypipes Ltd's intrinsic value (as of 08 November 2025) is 20.93 which is 241.99% higher the current market price of 6.12, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 17.5 Cr. market cap, FY2025-2026 high/low of 14.2/4.88, reserves of ₹-61.13 Cr, and liabilities of 54.48 Cr.
What is the Market Cap of Tijaria Polypipes Ltd?
The Market Cap of Tijaria Polypipes Ltd is 17.5 Cr..
What is the current Stock Price of Tijaria Polypipes Ltd as on 08 November 2025?
The current stock price of Tijaria Polypipes Ltd as on 08 November 2025 is 6.12.
What is the High / Low of Tijaria Polypipes Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Tijaria Polypipes Ltd stocks is 14.2/4.88.
What is the Stock P/E of Tijaria Polypipes Ltd?
The Stock P/E of Tijaria Polypipes Ltd is .
What is the Book Value of Tijaria Polypipes Ltd?
The Book Value of Tijaria Polypipes Ltd is 11.4.
What is the Dividend Yield of Tijaria Polypipes Ltd?
The Dividend Yield of Tijaria Polypipes Ltd is 0.00 %.
What is the ROCE of Tijaria Polypipes Ltd?
The ROCE of Tijaria Polypipes Ltd is 5.05 %.
What is the ROE of Tijaria Polypipes Ltd?
The ROE of Tijaria Polypipes Ltd is %.
What is the Face Value of Tijaria Polypipes Ltd?
The Face Value of Tijaria Polypipes Ltd is 10.0.